Hemochromatosis, HFE C282Y homozygosity, and polycystic ovary syndrome: Report of two cases and possible effects of androgens and hepcidin

Acta Haematologica

Volumn 126, Issue 3, 2011, Pages 138-140

  Barton, James C ^a,b   Barton, J Clayborn ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; HEPCIDIN; METFORMIN; ORAL CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; ARTICLE; BLOOD LEVEL; BODY MASS; CASE REPORT; FEMALE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; HYPERANDROGENISM; IRON DEPLETION; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PHLEBOTOMY; PRIORITY JOURNAL;

ADOLESCENT; ANDROGENS; ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MEMBRANE PROTEINS; POLYCYSTIC OVARY SYNDROME;

EID: 79959425814     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000328045     Document Type: Article

References (14)

1. Ganz T: Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006; 29-35, 507.
2. Barton JC, Edwards CQ, Phatak PD, Britton RS, Bacon BR: Classical and atypical HFE hemochromatosis; in Barton JC, Edwards CQ, Phatak PD, Britton RS, Bacon BR (eds): Handbook of Iron Overload Disorders. Cambridge, Cambridge University Press, 2010, pp 127-148.
3. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL: Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 2005; 9: 231-241. (Pubitemid 41507756)
4. van Dijk BA, Laarakkers CM, Klaver SM, Jacobs EM, van Tits LJ, Janssen MC, Swinkels DW: Serum hepcidin levels are innately low in HFE -related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol 2008; 142: 979-985.
5. Beutler E, Felitti V, Gelbart T, Ho N: The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000; 133: 329-337.
6. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL: Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 2005; 9: 231-241. (Pubitemid 41507756)
7. Huang A, Brennan K, Azziz R: Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010; 93: 1938-1941.
8. Luque-Ramirez M, Alvarez-Blasco F, Alpanes M, Escobar-Morreale HF: Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2011, DOI: 10.1210/jc.2010-2211.
9. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749. (Pubitemid 38766360)
10. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082. (Pubitemid 28500937)
11. Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S: Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010; 95: 4743-4747.
12. Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F: Androgen dependence of hirsutism, acne, and alopecia in women: Retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore) 2009; 88: 32-45.
13. Luque-Ramirez M, Alvarez-Blasco F, Botella- Carretero JI, Sanchon R, San Millan JL, Escobar-Morreale HF: Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care 2007; 30: 2309-2313. (Pubitemid 47359039)
14. Martinez-Garcia MA, Luque-Ramirez M, San Millan JL, Escobar-Morreale HF: Body iron stores and glucose intolerance in premenopausal women: Role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care 2009; 32: 1525-1530.